Advertisement

Adenomatous Polyposis Syndromes: MUTYH-Associated Polyposis

  • Maartje Nielsen
  • Stephan Aretz
Chapter

Abstract

MUTYH-associated polyposis was first described in 2002. It is inherited recessively, and patients usually develop between tens and hundreds of adenomas throughout life. The risk of developing colon cancer when surveillance is not started in time is very high. In this chapter the clinical aspects, cancer risk, mutation spectrum, risk for heterozygotes and tumour characteristics will be described.

Keywords

MUTYH- associated polyposis (MAP) Polyposis MUTYH 

References

  1. 1.
    Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingston AL, Williams GT, et al. Inherited variants of MYH associated with somatic G:C–>T:A mutations in colorectal tumors. Nat Genet. 2002;30(2):227–32.  https://doi.org/10.1038/ng828.CrossRefPubMedGoogle Scholar
  2. 2.
    Out AA, Tops CM, Nielsen M, Weiss MM, van Minderhout IJ, Fokkema IF, et al. Leiden open variation database of the MUTYH gene. Hum Mutat. 2010;31(11):1205–15.  https://doi.org/10.1002/humu.21343.CrossRefPubMedGoogle Scholar
  3. 3.
    Ohtsubo T, Nishioka K, Imaiso Y, Iwai S, Shimokawa H, Oda H, et al. Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res. 2015;43(7):3870–1.  https://doi.org/10.1093/nar/gkv264.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Michaels ML, Cruz C, Grollman AP, Miller JH. Evidence that MutY and MutM combine to prevent mutations by an oxidatively damaged form of guanine in DNA. Proc Natl Acad Sci U S A. 1992;89(15):7022–5.CrossRefGoogle Scholar
  5. 5.
    Boiteux S, Coste F, Castaing B. Repair of 8-oxo-7,8-dihydroguanine in prokaryotic and eukaryotic cells: properties and biological roles of the Fpg and OGG1 DNA N-glycosylases. Free Radic Biol Med. 2016.  https://doi.org/10.1016/j.freeradbiomed.2016.11.042.
  6. 6.
    Nielsen M, Morreau H, Vasen HF, Hes FJ. MUTYH-associated polyposis (MAP). Crit Rev Oncol Hematol. 2011;79(1):1–16.  https://doi.org/10.1016/j.critrevonc.2010.05.011;S1040-8428(10)00147-2 [pii].CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Aretz S, Tricarico R, Papi L, Spier I, Pin E, Horpaopan S, et al. MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events. Eur J Hum Genet. 2014;22(7):923–9.CrossRefGoogle Scholar
  8. 8.
    Miyaki M, Iijima T, Yamaguchi T, Hishima T, Tamura K, Utsunomiya J, et al. Germline mutations of the MYH gene in Japanese patients with multiple colorectal adenomas. Mutat Res. 2005;578(1–2):430–3.  https://doi.org/10.1016/j.mrfmmm.2005.01.017.CrossRefPubMedGoogle Scholar
  9. 9.
    Peterlongo P, Mitra N, Sanchez de Abajo A, de la Hoya M, Bassi C, Bertario L, et al. Increased frequency of disease-causing MYH mutations in colon cancer families. Carcinogenesis. 2006;27(11):2243–9.  https://doi.org/10.1093/carcin/bgl093.CrossRefPubMedGoogle Scholar
  10. 10.
    Kim DW, Kim IJ, Kang HC, Jang SG, Kim K, Yoon HJ, et al. Germline mutations of the MYH gene in Korean patients with multiple colorectal adenomas. Int J Color Dis. 2007;22(10):1173–8.  https://doi.org/10.1007/s00384-007-0289-8.CrossRefGoogle Scholar
  11. 11.
    Yanaru-Fujisawa R, Matsumoto T, Ushijima Y, Esaki M, Hirahashi M, Gushima M, et al. Genomic and functional analyses of MUTYH in Japanese patients with adenomatous polyposis. Clin Genet. 2008;73(6):545–53.  https://doi.org/10.1111/j.1399-0004.2008.00998.x.CrossRefPubMedGoogle Scholar
  12. 12.
    Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, et al. Prevalence and penetrance of major genes and polygenes for colorectal cancer. Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2016.  https://doi.org/10.1158/1055-9965.EPI-16-0693.
  13. 13.
    Dolwani S, Williams GT, West KP, Newman J, Stock D, Griffiths AP, et al. Analysis of inherited MYH/(MutYH) mutations in British Asian patients with colorectal cancer. Gut. 2007;56(4):593.  https://doi.org/10.1136/gut.2006.094532.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Prior TW, Bridgeman SJ. Identifying mutations for MYH-associated polyposis. Curr Protoc Hum Genet. 2010; Chapter 10:Unit 10 3.  https://doi.org/10.1002/0471142905.hg1013s64.
  15. 15.
    Nielsen M, J-vdB MC, Jones N, Vogt S, Tops CM, Vasen HF, et al. Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology. 2009;136(2):471–6.  https://doi.org/10.1053/j.gastro.2008.10.056;S0016-5085(08)01894-5 [pii].CrossRefPubMedGoogle Scholar
  16. 16.
    Gismondi V, Meta M, Bonelli L, Radice P, Sala P, Bertario L, et al. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas. Int J Cancer (Journal International du Cancer). 2004;109(5):680–4.  https://doi.org/10.1002/ijc.20054.CrossRefPubMedGoogle Scholar
  17. 17.
    Ricci MT, Miccoli S, Turchetti D, Bondavalli D, Viel A, Quaia M, et al. Type and frequency of MUTYH variants in Italian patients with suspected MAP: a retrospective multicenter study. J Hum Genet. 2017;62(2):309–15.  https://doi.org/10.1038/jhg.2016.132.CrossRefPubMedGoogle Scholar
  18. 18.
    Rouleau E, Zattara H, Lefol C, Noguchi T, Briaux A, Buecher B, et al. First large rearrangement in the MUTYH gene and attenuated familial adenomatous polyposis syndrome. Clin Genet. 2011;80(3):301–3.  https://doi.org/10.1111/j.1399-0004.2011.01699.x.CrossRefPubMedGoogle Scholar
  19. 19.
    Torrezan GT, da Silva FC, Krepischi AC, Santos EM, Ferreira Fde O, Rossi BM, et al. Breakpoint characterization of a novel large intragenic deletion of MUTYH detected in a MAP patient: case report. BMC Med Genet. 2011;12:128.  https://doi.org/10.1186/1471-2350-12-128.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Castillejo A, Vargas G, Castillejo MI, Navarro M, Barbera VM, Gonzalez S, et al. Prevalence of germline MUTYH mutations among Lynch-like syndrome patients. Eur J Cancer. 2014;50(13):2241–50.CrossRefGoogle Scholar
  21. 21.
    Gomez-Fernandez N, Castellvi-Bel S, Fernandez-Rozadilla C, Balaguer F, Munoz J, Madrigal I, et al. Molecular analysis of the APC and MUTYH genes in Galician and Catalonian FAP families: a different spectrum of mutations? BMC Med Genet. 2009;10:57.  https://doi.org/10.1186/1471-2350-10-57.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Abdelmaksoud-Dammak R, Miladi-Abdennadher I, Amouri A, Tahri N, Ayadi L, Khabir A, et al. High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis. Familial Cancer. 2012;11(3):503–8.  https://doi.org/10.1007/s10689-012-9543-5.CrossRefPubMedGoogle Scholar
  23. 23.
    Shinmura K, Kato H, Goto M, Yamada H, Tao H, Nakamura S, et al. Functional evaluation of nine missense-type variants of the human DNA glycosylase enzyme MUTYH in the Japanese population. Hum Mutat. 2016;37(4):350–3.  https://doi.org/10.1002/humu.22949.CrossRefPubMedGoogle Scholar
  24. 24.
    Shinmura K, Goto M, Tao H, Matsuura S, Matsuda T, Sugimura H. Impaired suppressive activities of human MUTYH variant proteins against oxidative mutagenesis. World J Gastroenterol. 2012;18(47):6935–42.  https://doi.org/10.3748/wjg.v18.i47.6935.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Shinmura K, Goto M, Tao H, Kato H, Suzuki R, Nakamura S, et al. Impaired 8-Hydroxyguanine repair activity of MUTYH variant p.Arg109Trp found in a Japanese patient with early-onset colorectal cancer. Oxidative Med Cell Longev. 2014.  https://doi.org/10.1155/2014/617351. Artn 617351.
  26. 26.
    Goto M, Shinmura K, Nakabeppu Y, Tao H, Yamada H, Tsuneyoshi T, et al. Adenine DNA glycosylase activity of 14 human MutY homolog (MUTYH) variant proteins found in patients with colorectal polyposis and cancer. Hum Mutat. 2010;31(11):E1861–74.  https://doi.org/10.1002/humu.21363.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Bai H, Grist S, Gardner J, Suthers G, Wilson TM, Lu AL. Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposis. Cancer Lett. 2007;250(1):74–81.  https://doi.org/10.1016/j.canlet.2006.09.016.CrossRefPubMedGoogle Scholar
  28. 28.
    Ali M, Kim H, Cleary S, Cupples C, Gallinger S, Bristow R. Characterization of mutant MUTYH proteins associated with familial colorectal cancer. Gastroenterology. 2008;135(2):499–507.  https://doi.org/10.1053/j.gastro.2008.04.035.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer (Journal International du Cancer). 2006;119(4):807–14.  https://doi.org/10.1002/ijc.21905.CrossRefPubMedGoogle Scholar
  30. 30.
    Isidro G, Laranjeira F, Pires A, Leite J, Regateiro F, Castro e Sousa F, et al. Germline MUTYH (MYH) mutations in Portuguese individuals with multiple colorectal adenomas. Hum Mutat. 2004;24(4):353–4.  https://doi.org/10.1002/humu.9282.CrossRefPubMedGoogle Scholar
  31. 31.
    Lubbe SJ, Di Bernardo MC, Chandler IP, Houlston RS. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol: Off J Am Soc Clin Oncol. 2009;27(24):3975–80.  https://doi.org/10.1200/JCO.2008.21.6853.CrossRefGoogle Scholar
  32. 32.
    Wang L, Baudhuin LM, Boardman LA, Steenblock KJ, Petersen GM, Halling KC, et al. MYH mutations in patients with attenuated and classic polyposis and with young-onset colorectal cancer without polyps. Gastroenterology. 2004;127(1):9–16.CrossRefGoogle Scholar
  33. 33.
    Croitoru ME, Cleary SP, Di Nicola N, Manno M, Selander T, Aronson M, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst. 2004;96(21):1631–4.  https://doi.org/10.1093/jnci/djh288.CrossRefPubMedGoogle Scholar
  34. 34.
    Theodoratou E, Campbell H, Tenesa A, Houlston R, Webb E, Lubbe S, et al. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer. 2010;103(12):1875–84.  https://doi.org/10.1038/sj.bjc.6605966.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Sieber OM, Lipton L, Crabtree M, Heinimann K, Fidalgo P, Phillips RK, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med. 2003;348(9):791–9.  https://doi.org/10.1056/NEJMoa025283.CrossRefPubMedGoogle Scholar
  36. 36.
    Nielsen M, Franken PF, Reinards TH, Weiss MM, Wagner A, van der Klift H, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet. 2005;42(9):e54.  https://doi.org/10.1136/jmg.2005.033217.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Sampson JR, Dolwani S, Jones S, Eccles D, Ellis A, Evans DG, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003;362(9377):39–41.CrossRefGoogle Scholar
  38. 38.
    Farrington SM, Tenesa A, Barnetson R, Wiltshire A, Prendergast J, Porteous M, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet. 2005;77(1):112–9.CrossRefGoogle Scholar
  39. 39.
    Nieuwenhuis MH, Vogt S, Jones N, Nielsen M, Hes FJ, Sampson JR, et al. Evidence for accelerated colorectal adenoma--carcinoma progression in MUTYH-associated polyposis? Gut. 2012;61(5):734–8.  https://doi.org/10.1136/gut.2010.229104.CrossRefPubMedGoogle Scholar
  40. 40.
    Balaguer F, Castellvi-Bel S, Castells A, Andreu M, Munoz J, Gisbert JP, et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. Clin Gastroenterol Hepatol. 2007;5(3):379–87.CrossRefGoogle Scholar
  41. 41.
    Fleischmann C, Peto J, Cheadle J, Shah B, Sampson J, Houlston RS. Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer. Int J Cancer. 2004;109(4):554–8.CrossRefGoogle Scholar
  42. 42.
    Avezzu A, Agostini M, Pucciarelli S, Lise M, Urso ED, Mammi I, et al. The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle. Cancer Lett. 2008;268(2):308–13.CrossRefGoogle Scholar
  43. 43.
    van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, et al. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res: Off J Am Assoc Cancer Res. 2008;14(1):139–42.  https://doi.org/10.1158/1078-0432.ccr-07-1705.CrossRefGoogle Scholar
  44. 44.
    Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009;136(4):1251–60.CrossRefGoogle Scholar
  45. 45.
    Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137(6):1976–85 e1-10.  https://doi.org/10.1053/j.gastro.2009.08.052.CrossRefPubMedGoogle Scholar
  46. 46.
    Walton SJ, Kallenberg FG, Clark SK, Dekker E, Latchford A. Frequency and features of duodenal adenomas in patients with MUTYH-associated polyposis. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2016;14(7):986–92.  https://doi.org/10.1016/j.cgh.2016.02.020.CrossRefGoogle Scholar
  47. 47.
    Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, et al. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer (Journal International du Cancer). 2016;139(7):1557–63.  https://doi.org/10.1002/ijc.30197.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Roberts ME, Riegert-Johnson DL, Thomas BC, Rumilla KM, Thomas CS, Heckman MG, et al. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome. Genet Med: Off J Am Coll Med Genet. 2014;16(9):711–6.  https://doi.org/10.1038/gim.2014.19.CrossRefGoogle Scholar
  49. 49.
    Nielsen M, Lynch H, Infante E, Brand R. MUTYH-associated polyposis. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al., editors. GeneReviews(R). Seattle: University of Washington; 1993, All rights reserved.Google Scholar
  50. 50.
    Ponti G, Ponz DL, Maffei S, Pedroni M, Losi L, Di Gregorio C, et al. Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet. 2005;68(5):442–7.CrossRefGoogle Scholar
  51. 51.
    Coleman P, Barnard NA. Congenital hypertrophy of the retinal pigment epithelium: prevalence and ocular features in the optometric population. Ophthalmic Physiol Opt. 2007;27(6):547–55.  https://doi.org/10.1111/j.1475-1313.2007.00513.x.CrossRefGoogle Scholar
  52. 52.
    Jones N, Vogt S, Nielsen M, Christian D, Wark PA, Eccles D, et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. Gastroenterology. 2009;137(2):489–94, 94 e1; quiz 725-6.  https://doi.org/10.1053/j.gastro.2009.04.047.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Jenkins MA, Croitoru ME, Monga N, Cleary SP, Cotterchio M, Hopper JL, et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2006;15(2):312–4.  https://doi.org/10.1158/1055-9965.EPI-05-0793.CrossRefGoogle Scholar
  54. 54.
    Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, et al. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer (Journal International du Cancer). 2011;129(9):2256–62.  https://doi.org/10.1002/ijc.25870.CrossRefGoogle Scholar
  55. 55.
    Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 2014;146(5):1208–11.e1-5.  https://doi.org/10.1053/j.gastro.2014.01.022.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Rennert G, Lejbkowicz F, Cohen I, Pinchev M, Rennert HS, Barnett-Griness O. MutYH mutation carriers have increased breast cancer risk. Cancer. 2012;118(8):1989–93.  https://doi.org/10.1002/cncr.26506.CrossRefPubMedGoogle Scholar
  57. 57.
    Zhu M, Chen X, Zhang H, Xiao N, Zhu C, He Q, et al. AluYb8 insertion in the MUTYH gene and risk of early-onset breast and gastric cancers in the Chinese population. Asian Pac J Cancer Prev. 2011;12(6):1451–5.PubMedGoogle Scholar
  58. 58.
    Wasielewski M, Out AA, Vermeulen J, Nielsen M, van den Ouweland A, Tops CM, et al. Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer. Breast Cancer Res Treat. 2010;124(3):635–41.  https://doi.org/10.1007/s10549-010-0801-7.CrossRefPubMedGoogle Scholar
  59. 59.
    Beiner ME, Zhang WW, Zhang S, Gallinger S, Sun P, Narod SA. Mutations of the MYH gene do not substantially contribute to the risk of breast cancer. Breast Cancer Res Treat. 2009;114(3):575–8.CrossRefGoogle Scholar
  60. 60.
    Out AA, Wasielewski M, Huijts PE, van Minderhout IJ, Houwing-Duistermaat JJ, Tops CM, et al. MUTYH gene variants and breast cancer in a Dutch case-control study. Breast Cancer Res Treat. 2012;134:219–27.CrossRefGoogle Scholar
  61. 61.
    Baudhuin LM, Roberts LR, Enders FT, Swanson RL, Mettler TA, Aderca I, et al. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients. J Cancer Res Clin Oncol. 2006;132(3):159–62.CrossRefGoogle Scholar
  62. 62.
    Pilati C, Shinde J, Alexandrov LB, Assie G, Andre T, Helias-Rodzewicz Z, et al. Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas. J Pathol. 2017;242(1):10–5.  https://doi.org/10.1002/path.4880.CrossRefPubMedGoogle Scholar
  63. 63.
    Scarpa A, Chang DK, Nones K, Corbo V, Patch AM, Bailey P, et al. Whole-genome landscape of pancreatic neuroendocrine tumours. Nature. 2017;543(7643):65–71.  https://doi.org/10.1038/nature21063.CrossRefPubMedGoogle Scholar
  64. 64.
    Grasso F, Giacomini E, Sanchez M, Degan P, Gismondi V, Mazzei F, et al. Genetic instability in lymphoblastoid cell lines expressing biallelic and monoallelic variants in the human MUTYH gene. Hum Mol Genet. 2014;23(14):3843–52.  https://doi.org/10.1093/hmg/ddu097.CrossRefPubMedGoogle Scholar
  65. 65.
    Boparai KS, Dekker E, Van Eeden S, Polak MM, Bartelsman JF, Mathus-Vliegen EM, et al. Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of Myh-Associated Polyposis (Map). Gastroenterology. 2008;135:2014–8.CrossRefGoogle Scholar
  66. 66.
    Church J, Kravochuck S. The “studded” rectum: phenotypic evidence of MYH-associated polyposis. Dis Colon Rectum. 2016;59(6):565–9.  https://doi.org/10.1097/DCR.0000000000000575.CrossRefPubMedGoogle Scholar
  67. 67.
    Nielsen M, de Miranda NF, van Puijenbroek M, Jordanova ES, Middeldorp A, van Wezel T, et al. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. BMC Cancer. 2009;9:184.  https://doi.org/10.1186/1471-2407-9-184.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    de Miranda NF, Nielsen M, Pereira D, van Puijenbroek M, Vasen HF, Hes FJ, et al. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression – a common event amongst DNA-repair-deficient colorectal cancers. J Pathol. 2009;219(1):69–76.  https://doi.org/10.1002/path.2569.CrossRefPubMedGoogle Scholar
  69. 69.
    Lipton L, Halford SE, Johnson V, Novelli MR, Jones A, Cummings C, et al. Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res. 2003;63(22):7595–9.PubMedGoogle Scholar
  70. 70.
    Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, et al. Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study. Br J Cancer. 2001;85(5):692–6.CrossRefGoogle Scholar
  71. 71.
    Middeldorp A, van Puijenbroek M, Nielsen M, Corver WE, Jordanova ES, ter HN, et al. High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas. J Pathol. 2008;216(1):25–31.CrossRefGoogle Scholar
  72. 72.
    Lefevre JH, Rodrigue CM, Mourra N, Bennis M, Flejou JF, Parc R, et al. Implication of MYH in colorectal polyposis. Ann Surg. 2006;244(6):874–9.CrossRefGoogle Scholar
  73. 73.
    Colebatch A, Hitchins M, Williams R, Meagher A, Hawkins NJ, Ward RL. The role of MYH and microsatellite instability in the development of sporadic colorectal cancer. Br J Cancer. 2006;95(9):1239–43.CrossRefGoogle Scholar
  74. 74.
    Morak M, Heidenreich B, Keller G, Hampel H, Laner A, de la Chapelle A, Holinski-Feder E.Biallelic MUTYHmutations can mimic Lynch syndrome.Eur J Hum Genet. 2014 Nov;22(11):1334-7. doi: 10.1038/ejhg.2014.15. Epub 2014 Feb 12.CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Segui N, Navarro M, Pineda M, Koger N, Bellido F, Gonzalez S, et al. Exome sequencing identifies MUTYH mutations in a family with colorectal cancer and an atypical phenotype. Gut. 2015;64(2):355–6.  https://doi.org/10.1136/gutjnl-2014-307084.CrossRefGoogle Scholar
  76. 76.
    Weren RD, Ligtenberg MJ, Kets CM, de Voer RM, Verwiel ET, Spruijt L, et al. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer. Nat Genet. 2015;47(6):668–71.  https://doi.org/10.1038/ng.3287.CrossRefGoogle Scholar
  77. 77.
    Rashid M, Fischer A, Wilson CH, Tiffen J, Rust AG, Stevens P, et al. Adenoma development in familial adenomatous polyposis and MUTYH-associated polyposis: somatic landscape and driver genes. J Pathol. 2016;238(1):98–108.  https://doi.org/10.1002/path.4643.CrossRefGoogle Scholar
  78. 78.
    Cardoso J, Molenaar L, de Menezes RX, van Leerdam M, Rosenberg C, Moslein G, et al. Chromosomal instability in MYH- and APC-mutant adenomatous polyps. Cancer Res. 2006;66(5):2514–9.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Clinical GeneticsLeiden University Medical CentreLeidenThe Netherlands
  2. 2.Institute of Human Genetics, Center for Hereditary Tumor Syndromes, University of BonnBonnGermany

Personalised recommendations